Your browser doesn't support javascript.
loading
Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulation.
Shekhtman, Louis; Cotler, Scott J; Ploss, Alexander; Dahari, Harel.
Afiliação
  • Shekhtman L; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA; Network Science Institute, Northeastern University, Boston, MA, USA.
  • Cotler SJ; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
  • Ploss A; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Dahari H; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. Electronic address: hdahari@luc.edu.
J Hepatol ; 76(5): 1229-1231, 2022 05.
Article em En | MEDLINE | ID: mdl-34995688

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite D / Hepatite D Crônica Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite D / Hepatite D Crônica Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article